The administration of the Cancer Center plays an essential role in maintaining operational efficiency within CCSG guidelines. In particular, the administration supports Cancer Center leadership in order to carry out the following functions: Administrative support and coordination for planning, evaluation, and overall management of the Cancer Center Communication with NCI and implementation of NCI policies and requests Central administration and management of resources and services Coordination of membership appointment, review, and communications Management of meetings, including scheduling, documenting, and follow-on actions Maintenance of Cancer Center records Management of CCSG finances, including CCSG developmental and planning funds Operational management and supervision of Shared Facilities and common equipment Laboratory space management Cancer Center administration must work closely with Institute administration to ensure adequate provision of services to meet Cancer Center needs and to adequately carry out the business of the Cancer Center in accordance with sound financial and federal compliance guidelines. CCSG support is requested for a portion of the salaries of the three associate directors who provide general administrative management, and CCSG financial management and oversight of the Shared Facilities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA010815-40
Application #
7944999
Study Section
Subcommittee G - Education (NCI)
Project Start
2009-04-15
Project End
2014-02-28
Budget Start
2009-04-15
Budget End
2010-02-28
Support Year
40
Fiscal Year
2009
Total Cost
$298,336
Indirect Cost
Name
Wistar Institute
Department
Type
DUNS #
075524595
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Jenkins, Russell W; Aref, Amir R; Lizotte, Patrick H et al. (2018) Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids. Cancer Discov 8:196-215
Barnoud, Thibaut; Budina-Kolomets, Anna; Basu, Subhasree et al. (2018) Tailoring Chemotherapy for the African-Centric S47 Variant of TP53. Cancer Res 78:5694-5705
Barbieri, Elisa; Trizzino, Marco; Welsh, Sarah Ann et al. (2018) Targeted Enhancer Activation by a Subunit of the Integrator Complex. Mol Cell 71:103-116.e7
Seo, Jae Ho; Agarwal, Ekta; Bryant, Kelly G et al. (2018) Syntaphilin Ubiquitination Regulates Mitochondrial Dynamics and Tumor Cell Movements. Cancer Res 78:4215-4228
Lu, Huimin; Bowler, Nicholas; Harshyne, Larry A et al. (2018) Exosomal ?v?6 integrin is required for monocyte M2 polarization in prostate cancer. Matrix Biol 70:20-35
Stout, Matthew C; Narayan, Shilpa; Pillet, Emily S et al. (2018) Inhibition of CX3CR1 reduces cell motility and viability in pancreatic adenocarcinoma epithelial cells. Biochem Biophys Res Commun 495:2264-2269
Hu, Xiaowen; Sood, Anil K; Dang, Chi V et al. (2018) The role of long noncoding RNAs in cancer: the dark matter matters. Curr Opin Genet Dev 48:8-15
Liu, Shujing; Zhang, Gao; Guo, Jianping et al. (2018) Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesis. Nat Commun 9:5426
Saglam, Ozlen; Conejo-Garcia, Jose (2018) PD-1/PD-L1 immune checkpoint inhibitors in advanced cervical cancer. Integr Cancer Sci Ther 5:
Papasavvas, Emmanouil; Lada, Steven M; Joseph, Jocelin et al. (2018) Analytical ART interruption does not irreversibly change pre-interruption levels of cellular HIV. AIDS :

Showing the most recent 10 out of 741 publications